WHO International Health Regulations Emergency Committee for the COVID-19 outbreak
- PMID: 32192278
- PMCID: PMC7285442
- DOI: 10.4178/epih.e2020013
WHO International Health Regulations Emergency Committee for the COVID-19 outbreak
Abstract
To discuss whether the coronavirus disease 2019 (COVID-19) outbreak constitutes a Public Health Emergency of International Concern (PHEIC), World Health Organization (WHO) organized the 15-member International Health Regulations Emergency Committee (EC). On January 22-23 and January 30, 2020, EC convened and discussed whether the situation in China and other countries would constitute PHEIC and issued recommendations for WHO, China and the international community. Based on the recommendations of EC, WHO declared the COVID-19 outbreak a PHEIC. One of the purposes of the declaration of PHEIC was to alarm countries with weak public health infrastructures to prepare promptly for emerging infectious diseases (EID) and provide WHO with a framework for proactively supporting those countries. On February 3, 2020, WHO proposed the 2019 COVID-19 Strategic Preparedness and Response Plan, which includes accelerating research and development (R&D) processes as one of three major strategies. On February 11-12, 2020, WHO held the Global Research and Innovation Forum: Towards a Research Roadmap for COVID-19. The fact that a COVID-19 R&D forum was the first meeting convened after the PHEIC declaration testifies to the importance of R&D in response to EID. Korea has demonstrated a remarkable capacity in its laboratory response by conducting high-throughput COVID-19 testing and utilizing innovative drive-through samplings. These measures for early detection and screening of cases should be followed by full efforts to produce research-based evidence by thoroughly analyzing epidemiological, clinical and immunological data, which will facilitate the development of vaccines and therapeutics for COVID-19. It is expected that Korea plays a global partner for COVID-19 research by actively participating in immediate and mid/long-term priorities jointly led by WHO and global partners.
Keywords: COVID-19; Emergency Committee; International Health Regulations; Public Health Emergency of International Concern; Research and development.
Conflict of interest statement
The author has no conflicts of interest to declare for this study.
Figures
Similar articles
-
Progress of COVID-19 Epidemic in Pakistan.Asia Pac J Public Health. 2020 May;32(4):154-156. doi: 10.1177/1010539520927259. Epub 2020 May 19. Asia Pac J Public Health. 2020. PMID: 32429679 Free PMC article.
-
From the handling of an outbreak by an unknown pathogen in Wuhan to the preparedness and response in the face of the emergence of Covid-19 in Mexico.Gac Med Mex. 2020;156(2):132-137. doi: 10.24875/GMM.M20000346. Gac Med Mex. 2020. PMID: 32285862 English.
-
Solidarity in response to COVID-19 outbreak in the Eastern Mediterranean Region.East Mediterr Health J. 2020 May 21;26(5):492-494. doi: 10.26719/2020.26.5.492. East Mediterr Health J. 2020. PMID: 32538438
-
An analysis of International Health Regulations Emergency Committees and Public Health Emergency of International Concern Designations.BMJ Glob Health. 2020 Jun;5(6):e002502. doi: 10.1136/bmjgh-2020-002502. BMJ Glob Health. 2020. PMID: 32546587 Free PMC article. Review.
-
COVID-19-A Novel Zoonotic Disease: A Review of the Disease, the Virus, and Public Health Measures.Asia Pac J Public Health. 2020 May;32(4):145-153. doi: 10.1177/1010539520931326. Epub 2020 May 30. Asia Pac J Public Health. 2020. PMID: 32475144 Review.
Cited by
-
Evaluation of the impact of the COVID-19 lockdown on the quality of life of patients monitored for cancer who practice an adapted physical activity: rugby for health.J Cancer Res Clin Oncol. 2022 Feb;148(2):425-439. doi: 10.1007/s00432-021-03621-7. Epub 2021 Apr 5. J Cancer Res Clin Oncol. 2022. PMID: 33821320 Free PMC article.
-
Unique presentations of aspergillosis endogenous endophthalmitis in two hospitalized patients with severe COVID-19.Indian J Ophthalmol. 2022 Apr;70(4):1421-1424. doi: 10.4103/ijo.IJO_2718_21. Indian J Ophthalmol. 2022. PMID: 35326072 Free PMC article.
-
Evaluation of the Neutralizing Antibodies Response against 14 SARS-CoV-2 Variants in BNT162b2 Vaccinated Naïve and COVID-19 Positive Healthcare Workers from a Northern Italian Hospital.Vaccines (Basel). 2022 Apr 29;10(5):703. doi: 10.3390/vaccines10050703. Vaccines (Basel). 2022. PMID: 35632457 Free PMC article.
-
Depression and anxiety associated with COVID- 19 pandemic among healthcare professionals in India- A systematic review and meta-analysis.Clin Epidemiol Glob Health. 2021 Oct-Dec;12:100888. doi: 10.1016/j.cegh.2021.100888. Epub 2021 Nov 4. Clin Epidemiol Glob Health. 2021. PMID: 34751253 Free PMC article. Review.
-
Retinal vessels modifications in acute and post-COVID-19.Sci Rep. 2021 Sep 29;11(1):19373. doi: 10.1038/s41598-021-98873-1. Sci Rep. 2021. PMID: 34588541 Free PMC article.
References
-
- World Health Organization International health regulations (2005. 2016 [cited 2020 Feb 12]. Available from: https://www.who.int/ihr/publications/9789241580496/en/
-
- Jee Y. PHEIC declared: what does WHO say? 2020 Feb 3 [cited 2020 Feb 10]. Available from: https://www.hankookilbo.com/News/Read/202002021589772383(Korean)
-
- World Health Organization Global research and innovation forum to mobilize international action in response to the novel coronavirus (2019-nCoV) emergency. 2020 Feb 11-12 [cited 2020 Mar 22]. Available from: https://www.who.int/news-room/events/detail/2020/02/11/default-calendar/....
-
- World Health Organization Pandemic influenza preparedness (PIP) framework. [cited 2020 Mar 20]. Available from: https://www.who.int/influenza/pip/en/
-
- World Health Organization 2019 Novel coronavirus (2019-nCoV): strategic preparedness and response plan: 2020 Feb 3. [cited 2020 Mar 22]. Available from: https://www.who.int/docs/default-source/coronaviruse/srp-04022020.pdf.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources